FUL · Fuller H B Co
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted income per common share attributable to H.B. Fuller non-GAAP | $3.49 | Nine Months Ended August 29, 2026 | — |
| Adjusted EBITDA non-GAAP | 656.51M | Trailing Twelve Months Ended August 29, 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 18.3% | Nine Months Ended August 29, 2026 | — |
| Adjusted effective income tax rate non-GAAP | 25.7% | Nine Months Ended August 29, 2026 | — |
| Adjusted gross profit non-GAAP | $315M | Q3 FY2026 | — |
| Adjusted gross profit margin non-GAAP | 33.1% | Nine Months Ended August 29, 2026 | — |
| Adjusted net income attributable to H.B. Fuller non-GAAP | 192.48M | Nine Months Ended August 29, 2026 | — |
|
|
|||
| Adjusted SG&A non-GAAP | $183M | Q3 FY2026 | — |
| Net debt non-GAAP | $1.96B | Q3 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Total debt 2.05B
-97.23M Less: Cash and cash equivalents
= Net debt 1.96B
|
|||
| Net Debt-to-Adjusted EBITDA non-GAAP | 3 | August 29, 2026 | — |
| Net working capital non-GAAP | 693.53M | August 29, 2026 | — |
| Net working capital as a percentage of annualized net revenue non-GAAP | 18.5% | Q3 FY2026 | — |
| Organic Growth non-GAAP | 0.4% | Nine Months Ended August 29, 2026 | — |
| Segment adjusted EBITDA margin non-GAAP | 23.8% | Three Months Ended August 29, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FUL
this stock
Fuller H B Co
|
$2.69B | -16.8% | -4.7% | 14.0 | 5.4% |
|
LIN
Linde PLC
|
$216.61B | +11.3% | +3.0% | 30.3 | 1.3% |
|
AIQUF
L Air Liquide SA /Fi
|
$121.25B | +2.7% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$79.89B | -0.2% | +2.1% | 30.4 | 2.6% |
|
ECL
Ecolab Inc.
|
$78.35B | +4.6% | +2.2% | 37.5 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FUL | -1.5% | -8.1% | -22.3% | -10.0% | -16.8% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -0.8% | -8.2% | -34.5% | -9.4% | -28.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.